Biodesix Inc
corporate_fare Company Profile
Biodesix Inc (NASDAQ:BDSX) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for BDSX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for BDSX spans SCHEDULE 13D/A, 4, 10-Q, 8-K.
Recent high-impact activity:
- Schuler's Biodesix Stake Hits 22.3% After $1.0M Post-Guidance-Cut Buy
- 10% Owner Jack Schuler Buys 100,000 Biodesix Shares for $1.0M After Guidance Cut
- Biodesix Sinks 29% After Q3 Revenue Miss, 2026 Guidance Cut to $101M-$103M
- Biodesix 10-Q: Q3 Revenue $24.0M, Net Loss Narrows to $8.0M, Cash $28.4M
- Biodesix Q3 Revenue Misses, Full-Year 2026 Guidance Cut to $101M-$103M
Financial Snapshot
Short Interest & Short Volume
2.46 days to coverFINRA reported short interest of 210,018 shares in BDSX as of the October 30, 2026 settlement, a 0.3% increase from the prior period — about 2.5 days to cover at its recent average daily volume. On November 20, 2026, 53.3% of BDSX volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for BDSX, detected from its recent SEC filings · based on capital-structure filings through 2026-05-29.
Resale Offering by Selling Stockholder · Origin of Shares
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →